ST. PAUL, MN -- (MARKET WIRE) -- December 15, 2006 -- GelStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain and inflammation, is pleased to announce the launch of a direct response TV advertisement effort. GelStat has signed an agreement with a leading direct response media company, and has successfully passed their initial review process for moving forward with a direct-to-consumer marketing program for the GelStat Migraine product line. Production of the initial TV commercial is expected to commence immediately, with direct response commercials expected to begin airing within 45 days.
